Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytotoxic DNA crosslinking agents are not a single molecular target but rather a class of chemical compounds used primarily as anticancer drugs. They function by forming covalent bonds between two nucleotides on the same or opposite strands of cellular DNA—a process known as DNA crosslinking. This disrupts essential cellular processes including DNA replication and transcription, ultimately triggering cell death through apoptosis. The most clinically relevant forms are alkylating agents (such as nitrogen mustards) and platinum-based compounds like cisplatin. These agents have been foundational components of chemotherapy regimens since their introduction following observations from chemical warfare research during World War II. Their effectiveness is particularly notable against rapidly dividing cancer cells; however, they also damage normal proliferative tissues resulting in significant side effects. The term "cytotoxic DNA crosslinking agent" does not refer to any specific protein target such as an enzyme or receptor but instead describes a pharmacological action shared by several structurally diverse molecules. Therefore it is not considered a canonical therapeutic target itself—it is more accurately described as a drug mechanism category rather than an individual molecular entity suitable for structured database entries about targets. In summary: "Cytotoxic DNA crosslinking agent" refers broadly to any compound capable of inducing lethal covalent linkages within cellular genetic material—a property exploited therapeutically against cancer but associated with substantial risks due its lack of selectivity for malignant over healthy tissue.
Drugs in this category act by forming covalent bonds between nucleotides within the same strand or between opposite strands of the DNA double helix. This results in either intra-strand or inter-strand crosslinks that block essential processes like replication and transcription, leading to cell cycle arrest and apoptosis. The most cytotoxic lesions are interstrand crosslinks because they prevent strand separation required for both replication and transcription.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytotoxic DNA crosslinking agent.